Skip to main content
Parasite logoLink to Parasite
. 2013 Dec 12;20:52. doi: 10.1051/parasite/2013051

Application of the NucliSENS easyMAG system for nucleic acid extraction: optimization of DNA extraction for molecular diagnosis of parasitic and fungal diseases

Application du système NucliSENS easyMAG pour l’extraction des acides nucléiques : optimisation de l’extraction d’ADN pour le diagnostic moléculaire des parasitoses et mycoses

Fakhri Jeddi 1,2, Renaud Piarroux 1,2, Charles Mary 1,2,*
PMCID: PMC3859032  PMID: 24331004

Abstract

During the last 20 years, molecular biology techniques have propelled the diagnosis of parasitic diseases into a new era, as regards assay speed, sensitivity, and parasite characterization. However, DNA extraction remains a critical step and should be adapted for diagnostic and epidemiological studies. The aim of this report was to document the constraints associated with DNA extraction for the diagnosis of parasitic diseases and illustrate the adaptation of an automated extraction system, NucliSENS easyMAG, to these constraints, with a critical analysis of system performance. Proteinase K digestion of samples is unnecessary with the exception of solid tissue preparation. Mechanically grinding samples prior to cell lysis enhances the DNA extraction rate of fungal cells. The effect of host-derived nucleic acids on the extraction efficiency of parasite DNA varies with sample host cell density. The optimal cell number for precise parasite quantification ranges from 10 to 100,000 cells. Using the NucliSENS easyMAG technique, the co-extraction of inhibitors is reduced, with an exception for whole blood, which requires supplementary extraction steps to eliminate inhibitors.

Keywords: Nucleic acids extraction, Molecular diagnosis, Parasitic diseases, qPCR

1. Introduction

The field of molecular diagnosis and epidemiology of parasitic diseases and mycoses is constantly evolving. As is the case for other infectious diseases, diagnostic efforts have primarily focused on developing polymerase chain reaction (PCR) assays for a wide spectrum of parasitic diseases. Based on a Medline literature review (January 2013) of terms matching “PCR diagnosis of parasitic diseases” in reports published during the last 22 years, seven references were found for the year 1990, 99 for 1995, 170 for 2000, 329 for 2005, 522 were found for 2010, and 637 for 2012. The total number of references for the period 1990–2012 was 5,398. Most PCR assays are employed for disease diagnosis, epidemiologic studies, or polymorphism-based isolate genotyping [13, 17]. Unlike the evolution of PCR technology, optimization of DNA extraction techniques has remained neglected. In comparison to PCR-based diagnoses, the term “nucleic acids extraction and parasitic diseases” was referenced in Medline in 274 articles published between 1990 and 2012. Current extraction methods are based on silica adsorption, which are more convenient and safer than the former phenol chloroform methods. Routine laboratory analysis led to an automation of the process and highlighted the need to adapt the technique based on the characteristics of the biological samples.

Currently, automated nucleic acid extraction can be performed using two approaches as follows:

  • mechanical handling of the silica columns, which is complex due to the washing steps that require either centrifugation or vacuum.

  • application of silica coupled to magnetic particles, which is more efficient and can be automated. At least five commercially available systems incorporate this methodology (QiagenEZ1 and QIAsymphony, both from Qiagen; the Maxwell 16 System from Promega BioSciences; the MagNA Pure system from Roche Diagnostics and the NucliSENS easyMAG system from BioMerieux). The principal difference between these systems involves the nature of the lysis process. The NucliSENS easyMAG system employs strong denaturing reagents, while the other techniques involve a milder lysis step using tensio-active agents associated with enzymatic proteolysis of the sample. However, the NucliSENS easyMAG process must be optimized for the molecular diagnosis of parasitic diseases and mycosis, as the operating protocols were initially established for the molecular diagnosis of viral diseases.

The aim of this study was to adopt sample processing and optimize the method for parasitic load quantification using the semi-automated NucliSENS easyMAG system for nucleic acid extraction. In this report, we assess system performance, limits, and specific requirements for parasitological studies.

2. Materials and methods

2.1. Study design

Our goal was to optimize sample processing variables such as the optimal cell number range for parasite quantification, sample pre-treatment with proteinase K (PK) digestion, mechanical grinding, and the detection of PCR inhibitors in the recovered DNA solution. The experiments were assessed via quantitative PCR (qPCR). These elements are summarized in Figure 1.

Figure 1.

Figure 1.

Study design.

2.2. Nature of the samples

We analyzed a panel of various types of cells and tissues that are commonly encountered during the routine diagnosis of parasitic diseases.

The THP1 cell line (ATCC TIB-202), which was grown in RPMI medium (Gibco ref. 52400-025, Life Technologies), represented the host cells and was used to analyze the sensitivity and saturation of the extraction process.

Leishmania infantum (MCAN/82/GR/MON497) promastigotes, which were representative of protozoa without cell wall or cystic stages, were grown in RPMI medium. This parasite harbors two kinds of nucleic acids: the nuclear DNA and the kinetoplastic DNA, essentially composed of small circular supercoiled double-stranded DNA (minicircles). This property will allow us to study the possible difference of affinity of these molecules for the silica by performing extractions on various numbers of cells and simultaneous quantification of nuclear and kinetoplastic targets.

To test the influence of system saturation with human DNA, either artificial samples were prepared by mixing THP1 cells with Leishmania at various proportions or the cells were tested separately. PCR inhibition by residual hemoglobin was assessed following DNA extraction of human blood mixed with Leishmania parasites.

Stool samples containing either Cryptosporidium oocysts (60 positive samples out of 130 samples as assessed via microscopic examination) or Giardia cysts (four samples) represented the cystic stage of protozoa. Diagnosis was established via microscopy. As stool samples represent a complex medium, 70 samples without parasitic elements were also included to assess for the removal of inhibitors.

Candida and Aspergillus harbor a cell wall that protects from cell lysis. We used Candida albicans cells (ATCC 10231) and Aspergillus fumigatus mycelium (ATCC 13073), which were grown in Sabouraud’s liquid medium for 4 days.

Assays were performed on 820 plasma samples and 428 bronchoalveolar lavages (BAL) for the detection of Aspergillus DNA, of which 18 were positive. All human-derived samples were anonymized according to the French legislation on Biological Research.

2.3. Mechanical grinding of samples

As encountered with plant DNA purification [10], mechanical disruption improves the yield of DNA extraction from cells with a cell wall or parasite cysts, prior to chemical and/or enzymatic lysis.

We tested two mechanical grinding devices as follows:

  • a vortex (Vortex-Genie 2, Scientific Industries) with a tube holder (MO BIO vortex adapter ref. 800-606-6246, MO BIO Laboratories) and 2-mL tubes containing approximately 25 glass beads (Sigma ref. G1152).

  • a high-power mechanical grinder (FastPrep 24, MP Biomedicals) set at maximum power for 1 min, using disposable tubes containing ceramic beads (Lysing Matrix D, MP Biomedicals).

In these conditions, heating does not exceed 35 °C so a cooling device was considered unnecessary.

2.4. Biological sample pre-treatment

2.4.1. Stool samples

Stool samples (200 mg) were suspended in 800 μL of lysis buffer in a microtube containing ceramic beads. After a 1-min shaking step using the FastPrep system at max power and 10-min incubation at room temperature, the microtubes were centrifuged for 10 min at 10,000 g and 200 μL of supernatant was submitted to extraction.

2.4.2. Blood samples

Whole blood (sample volumes less than 250 μL) was directly applied for extraction, as recommended by the manufacturer. For larger sample volumes, we tested re-extraction methods as described below.

2.4.3. Cell suspensions

Cells lacking a cell wall were suspended directly in lysis buffer.

Cells protected by a cell wall, such as yeasts, filamentous fungi, and protozoan cysts, or host tissues likely to contain these elements were mechanically ground in lysis buffer prior to extraction.

2.4.4. Plasma samples

Plasma, which was mixed directly with lysis buffer prior to extraction, was used to detect free Aspergillus DNA.

2.5. Proteinase K digestion

We analyzed the effects of PK digestion prior to DNA extraction from THP1 cells and Leishmania. All PK (Qiagen ref. 19131) treatments were performed overnight at 2 mg/mL (final concentration) in 0.1X ATL lysis buffer (Qiagen ref. 19076) at 56 °C.

2.6. NucliSENS easyMAG technology

NucliSENS easyMAG technology is based on the Boom technique [5], utilizes magnetic silica particles, and processes 24 samples simultaneously. This technology allows for the dynamic capture of nucleic acids and the washing of silica without loss of material.

2.6.1. Sample lysis

Boom lysis buffer contains 5 M guanidinium thiocyanate, a powerful dissociating and denaturing agent, plus tensio-active compounds. Direct lysis is the most frequently used technique; the sample volume should not exceed 1 mL to respect the ratio between sample volume and lysis buffer volume (1 volume for 2 volumes, respectively). External lysis saves time and enhances the safety of sample manipulation and transport.

2.6.2. DNA adsorption

Adsorption of nucleic acids occurs in lysis buffer at neutral pH levels. The volume of the magnetic silica suspension can vary between 50 μL and 140 μL (as recommended by the manufacturer). Preliminary experiments showed that 50 μL of silica is sufficient for samples with cell numbers inferior to 104. However, 140 μL of silica suspension is required for high-density samples, such as blood and solid tissues. All assays described in the current report were performed using 140 μL of silica suspension. Silica was added manually and homogenized thoroughly.

2.6.3. Washing

The initial washing step was performed using a buffer containing guanidinium thiocyanate to maintain high stringency, and the final steps were performed at a neutral pH level with high salt concentrations to retain the nucleic acids adsorbed on the silica matrix.

2.6.4. Elution

The elution step was performed at 70 °C in a volume that can vary between 25 μL and 110 μL at pH >8.0. The choice of elution volume essentially depends on the expected DNA quantity, the possible presence of inhibitors, and the volume required for amplification. The elution volume was 50 μL with an exception for the stool samples (elution volume 100 μL). The nucleic acids were stored at −40 °C.

2.6.5. Re-extraction

The re-extraction experiments were performed on blood sample volumes superior to 250 μL, as residual hemoglobin present in the corresponding eluates inhibits PCR amplification.

We prepared three sets of five blood samples; each tube contained 400 μL of blood and 104 Leishmania. Two re-extraction experiments were performed. The eluted DNA isolated from the first set of samples was processed using new magnetic silica and a new cassette. In contrast, the eluate isolated from the second set of samples was mixed a second time with the magnetic silica in the cassette used for the initial extraction.

A single extraction was performed on the third set, which served as a control.

An additional control consisted in direct extraction of 104 washed Leishmania promastigotes.

2.7. QIAamp DNA Mini kit

We compared the DNA yield obtained from cell suspensions using the NucliSENS easyMAG system and the QIAamp DNA Mini kit (Qiagen ref. 51034). The QIAamp DNA Mini kit was used according to the manufacturer’s specifications, with the exception of PK digestion, which was extended to 12 h to obtain the highest extraction yield [14].

2.8. Quantitative PCR assays

A comparison between the various extraction assays was performed via PCR quantification of the targets present in each DNA sample. The samples were compared by means of absolute quantification or relative comparisons were based on the difference in cycle threshold (Ct) values obtained from the analysis of amplification curves.

The following qPCR assays were employed to quantify either human or parasitic DNA:

  • human albumin gene [12].

  • Leishmania kinetoplastic DNA [14] and Leishmania DNA polymerase [15].

  • Candida albicans- and Aspergillus fumigatus-specific PCR [20].

  • Cryptosporidium-specific PCR [8].

  • Giardia-specific PCR [2].

Each of these systems employed hydrolysis probes (Taqman) as reporter and quantitative results were calculated applying standard curves generated by using serial dilutions of plasmid DNA containing the target sequences. TA cloning of the corresponding amplicons was performed using a TOPO TA cloning kit (Invitrogen ref. K4520-01, Life Technologies). Plasmids were amplified, purified from bacteria, and quantified via spectrophotometry prior to use. The results were expressed as the number of target sequence copies or the number of parasitic cells when the gene copy number was known.

2.9. Identification of inhibitors

The identification of inhibitors was performed on all samples using an M13 plasmid containing foreign DNA (Applied Biosystems part # 360364, Life Technologies). This plasmid was added to DNA samples to yield 20 copies per reaction tube. A qPCR assay targeting this plasmid (using M13 universal primers and a Taqman probe specific for the DNA insert) was performed for which the PCR was positive, thereby indicating the absence of inhibitors.

In addition to this initial assay, all samples assessed using Aspergillus DNA-specific qPCR were tested at two concentrations: 1μL of the eluate and 1μL of a 1/20 dilution of the eluate. The expected difference in Ct values between the two concentrations is 4.33 in the absence of inhibitors. We consider a difference in Ct values inferior to 3.5 as partial inhibition.

2.10. Statistical analysis

Statistical analyses were conducted using Statview 5 software (SAS Institute, Cary, USA).

3. Results

3.1. Proteinase K digestion is unnecessary for the treatment of Leishmania and human cell suspensions

Figure 2 presents the results of DNA extraction from THP1 cells (1A, ranging from 1 to 1,000) and Leishmania (1B, ranging from 1 to 10,000) and the influence of PK digestion. No significant differences were observed between the experiments performed with and without PK digestion. Extractions performed using a QIAamp DNA Mini kit following PK digestion of Leishmania showed comparable results.

Figure 2.

Figure 2.

Influence of proteinase K digestion (56 °C overnight) on DNA extraction. Graph A shows the Ct values obtained by quantifying THP1 cell DNA derived from direct extraction with the NucliSENS easyMAG system and extraction performed on the same quantity of cells following overnight (ON) digestion with Proteinase K. Graph B shows Leishmania quantification after extraction with the NucliSENS easyMAG system both with and without PK and quantification after extraction using a QIAamp DNA Mini kit after ON digestion with PK.

3.2. Stability of the lysates

We prepared six identical lysates from stool samples containing Cryptosporidium and buffy coat samples containing Leishmania. Two of these lysates were extracted within 2 h after lysis, two were extracted after 3 days, and the remaining two were extracted after 1 week. The lysates were conserved at room temperature, mean Ct were 31.3 ± 0.25 and 18.85 ± 0.45 for Cryptosporidium and Leishmania respectively; we did not observe a significant variation between the results obtained after different storage times (p > 0.15).

3.3. Mechanically grinding cysts and fungi improves the extraction yield

We first assessed the influence of mechanical grinding on the DNA extraction yield with Candida albicans cells and Aspergillus fumigatus mycelium.

Vortexing plus glass-bead treatment disrupted Candida cell wall after 5 min of agitation; however, this treatment was ineffective in disrupting the cell wall of filamentous fungi (Figure 3A).

Figure 3.

Figure 3.

Results of the extraction experiments performed on yeast (Candida albicans) and filamentous fungi (Aspergillus fumigatus). A presents the kinetics of the extraction process after vortexing and glass-bead treatment. B shows the differences in DNA quantity obtained from fungal cells using the FastPrep system (with) compared to the same process without grinding.

The FastPrep system increased the extraction efficiency for both Candida and Aspergillus; the difference in Ct between direct lysis and lysis plus cell wall disruption was 7.8 and 8.8 for Candida and Aspergillus, respectively (Figure 3B). As the resulting values were multiplied by 222 (27.8) and 445 (28.8), respectively, the initial yield (without disruption) was estimated to be less than 0.5% of the initial fungal DNA content.

Mechanical disruption by means of the FastPrep instrument and ceramic beads was also performed on stool samples that were tested positive for Cryptosporidium sp. and Giardia intestinalis cysts. For each sample, equal quantities of material were subjected to extraction either before or after disruption. Table 1 presents the results of the corresponding qPCR assay. Each sample was tested in quadruplicate, and a 3.5-fold (p = 0.03) and a 66-fold (p = 0.005) increase was observed for Cryptosporidium and Giardia, respectively. Regarding the Giardia test, two out of four assays without mechanical disruption were negative (Table 1). Although these samples yielded negative PCR results, parasite cysts were observed by microscopy.

Table 1.

Quantification of DNA following extraction from stool samples (Cryptosporidium and Giardia) and white blood cell samples (Leishmania). This table presents the number of positive experiments and the mean number of molecular targets detected from four different samples for each parasite. The same quantity of each sample was tested with and without FastPrep disruption.

Without disruption
After FastPrep disruption
Positive PCR Mean quantity Cells/tube Positive PCR Mean quantity Cells/tube p value
Cryptosporidium parvum 4/4 547 4/4 1940 0.03
Giardia intestinalis 2/4 9.5 4/4 636 0.005
Leishmania infantum 4/4 309 4/4 285 NS

Regarding the Leishmania cell suspensions, mechanical disruption did not improve DNA yield.

3.4. The easyMAG system efficiently removed PCR inhibitors

We tested 1,280 samples (plasma and BAL) for the presence of Aspergillus DNA. We did not observe a situation in which both the 1/20 DNA dilution yielded a positive PCR result and the undiluted sample was negative. Furthermore, the M13 plasmid PCR was never inhibited. These results indicate the absence of total PCR inhibition. Eighteen samples were tested positive for Aspergillus DNA. Although, the plasmid PCR was not affected, we observed variations in Ct values between pure and diluted DNA, thereby suggesting the presence of inhibitors in some samples (Figure 4). In all cases, the residual inhibitor concentration was insufficient to induce complete inhibition of DNA amplification.

Figure 4.

Figure 4.

Identification of PCR inhibitors in 18 biological samples positive for Aspergillus. Graph A: Ct values obtained from pure and diluted DNA samples (dilution rate 1/20). Graph B: Ct values obtained with 20 copies of a plasmid DNA systematically added to the same biological samples (undiluted and diluted) and a negative control sample (NC).

In DNA extracted from stool samples, 1 case of plasmid inhibition was observed among 130 samples.

The presence of residual hemoglobin after DNA extraction from whole blood is a known cause of PCR inhibition. Using the NucliSENS easyMAG system, PCR inhibition is frequently observed when more than 250 μL of blood is subjected to extraction. To avoid this problem, we tested three technical approaches, using 400 μL of blood containing 104 Leishmania. We failed to amplify Leishmania DNA in eluate derived from a single extraction. In contrast, inhibitors were successfully removed following the re-extraction of DNA with either new silica matrix or the silica used for the initial extraction, and 10,880 and 8,600 parasites/tube were recovered, respectively. A single extraction performed directly on a suspension of 104 purified Leishmania served as a control and yielded 10,400 parasites/tube.

3.5. Extraction yield varied with cell density

We first tested the saturation limit of the silica matrix by testing increasing quantities of Leishmania or THP1 cells. Figure 5 presents the variation in DNA extraction yield in relation to cell number. For Leishmania, saturation of the silica matrix (140 μL is the largest volume recommended by the manufacturer) was observed with 105 cells, while for THP1 monocytes, saturation was observed with greater than 104 cells.

Figure 5.

Figure 5.

Yield of DNA extraction from Leishmania and THP1 cells using the NucliSENS easyMAG system.

Next, we performed an experiment to assess the influence of various quantities of host cells (THP1 ranging from 0 to 106 cells) on the extraction of Leishmania DNA (ranging from 0 to 106 cells). All DNA solutions were tested for Leishmania abundance in duplicate using a qPCR assay targeting kinetoplastic DNA. Composition of the samples and the results of Leishmania quantification are summarized in Figure 6. Parasitic DNA extraction was impaired when more than 104 host cells were present in the sample, which is generally encountered in most human samples. Strikingly, the presence of 102–103 host cells seemed to enhance the extraction yield of low parasite-density samples.

Figure 6.

Figure 6.

Influence of the quantity of human cells (THP1 cells) on Leishmania quantification at various concentrations of host cells and parasites.

To better assess this paradoxical effect, we tested the hypothesis of a differential affinity between double-stranded circular DNA (kinetoplastic DNA) and genomic DNA. We performed DNA extractions from Leishmania in the range of 102–105 in the presence of a constant number of human cells (103). As shown in Figure 7, the affinity of the two types of parasitic DNA was nearly identical for high quantities of parasites (equal or superior to 103), while for lower quantities, kinetoplastic DNA showed a higher affinity for the silica matrix.

Figure 7.

Figure 7.

Variation of the ratio between kinetoplastic DNA and nuclear DNA extraction with various Leishmania quantities in the presence of 103 THP1 cells.

4. Discussion

Nucleic acid extraction is the first step in the molecular diagnosis and molecular epidemiology of infectious diseases. Due to the low proportion of parasitic DNA relative to host nucleic acid present in samples, the extraction process should be optimized to achieve highly sensitive, parasite-specific sequence detection. For the molecular quantification of parasites, the DNA extraction step should also be quantitative.

Several factors influence the quality and quantity of extracted nucleic acids, including the nature and cell content of the biological samples, the presence of PCR inhibitors, the cell wall of bacteria or fungi, and the cystic stage of the parasite.

Regardless of the DNA isolation method, it is crucial to perform sample pre-treatment prior to nucleic acid purification for several reasons.

First, this step allows for cell concentration from large-volume or low-cell density samples. This concentration step may eliminate elements such as plasma, red blood cells, and anticoagulants, which contain molecules that may interfere with downstream assays. The presence of free parasitic DNA in biological fluids, particularly in circulating blood, has been described for aspergillosis [3, 24], candidiasis [11], and leishmaniasis [7]. This free parasite DNA can either be removed or retained during the extraction process depending on the aim of the study.

Second, protein denaturation and/or hydrolysis are necessary to obtain the optimal extraction yield. Most techniques involve PK digestion prior to cell lysis. In a previous study [14] using the QIAamp DNA Mini kit, we showed that the PK digestion step should be extended to obtain a near complete extraction, a key element for precise quantification. The degree of stringency of many lysis buffers included in commercial kits varies, and most kits involve mild denaturation steps with reagents that enable PK activity. Using the NucliSENS easyMAG system, PK digestion is unnecessary for cell suspensions, which saves time and prevents the loss of material. Strong dissociation is observed using the Boom technique with 5 M guanidinium thiocyanate [5], which inhibits PK digestion and other biological activities, even viral infectivity. However, PK digestion is necessary for the complete dissociation of solid tissues and should therefore be performed prior to the addition of such lysis buffer. In a recent study about molecular diagnosis of cryptosporidiosis [16], we tested nine extraction methods: two of them, Nucleospin and QiaAmp DNA, showed that proteinase K treatment allows cyst disruption as supplementary mechanical grinding does not improve the DNA output. Concerning Giardia cysts PK digestion seems to be insufficient for cyst disruption and mechanical breakage should be performed [1]. Third, the dissociation capacity of lysis buffer is generally insufficient to completely disrupt the cell wall of filamentous fungi or cystic stages of parasites. In these cases, the mechanical disruption of cells notably improves the extraction yield and gives better results than the enzymatic treatment with PK, thereby considerably enhancing the detection sensitivity of such pathogens as mentioned by Nawrot [18]. Although vortexing with glass beads was sufficient for yeast treatment, filamentous fungi extraction yield was only enhanced using high-power mechanical grinding. DNA extraction from filamentous fungi or yeast performed without mechanical disruption resulted in a low extraction yield, which may largely explain the lack of sensitivity observed in the molecular diagnosis of systemic mycoses [6] using conventional PCR or real-time PCR. Sonication has been described as the most powerful method for disrupting cell walls [9]; however, this process induces DNA fragmentation. Therefore, mechanical grinding remains an optimal alternative for DNA extraction.

A combination of powerful mechanical disruption and dissociation using Boom lysis buffer yielded a DNA output identical to that obtained using PK digestion and allowed for the recovery of nucleic acids in less than 1 h. The NucliSENS easyMAG system allows for extraction even from low-cell density samples, as this technique allows for the recovery of DNA from as few as 10 cells (as shown in Figures 2, 5, and 6). In this case, DNA samples should be recovered in a small elution volume to increase both the concentration and the probability of detecting pathogen DNA.

In contrast, the saturation limit of the easyMAG system is in the range of 104–105 cells, while some kits using silica columns are able to bind DNA from more than five million cells without a considerable loss [19]. Therefore, this technique requires a lower quantity of sample than the classical column extraction systems to achieve accurate quantification of both parasitic and host DNA [23]. Exceeding the saturation limit of the silica matrix would lead to underestimate the parasitic load of the biological sample [21] and to overestimate the real DNA content when preparing DNA standard solutions from quantified parasite’s suspensions. For qualitative analysis and epidemiological studies, the extraction yield does not affect the results (e.g., the presence or absence of the parasite target sequence). Therefore, a high quantity of cells can be applied, as the larger the sample, the higher the probability of detecting parasitic DNA. Consequently, the quantity of initial material should be adapted depending on the aim of the assay.

DNA extraction from macroparasites is generally performed for genotyping or subtyping parasites; therefore, the performance of the extraction process is not critical [4, 22].

Research of PCR inhibitors is necessary for assessing the quality of molecular diagnosis of infectious diseases. Using NucliSENS EasyMAG, we found a low frequency of inhibitors in DNA from stool samples: this may be associated with the process itself and/or the quantity of stool samples used for extraction (approximately 40 mg) as other commercial kits recommend 200 mg of starting material (QIAamp Stool kit, Qiagen). For plasma and BAL samples, potential PCR inhibition of the M13 plasmid was always found negative and testing a dilution of the positive DNA sample via the Aspergillus PCR showed a partial inhibition in most cases which would result in an underestimation of the fungal load. Although the specific PCR seems to be the optimal test to evaluate inhibition, it is only applicable to the positive samples, so use of an external system is necessary even if its sensitivity to inhibitors is different.

The current easyMAG protocols do not support direct extraction from blood volumes exceeding 250 μL. If larger volumes are used, residual hemoglobin inhibits subsequent PCRs. Re-extraction protocols may resolve this problem without resulting in a loss of material, even using the silica matrix utilized for the initial extraction.

Our results demonstrate that affinity of the silica matrix for the DNA varies with the conformation of the DNA and that the amplitude of the difference depends on the DNA concentration. This could partially explain the increased quantity observed for kinetoplastic DNA PCR with a low density of parasites and a medium density of host cells. Furthermore, the NucliSENS easyMAG system allows for simultaneous extraction of both DNA and RNA. As these nucleic acids are not dissociable, extraction experiments, especially those assessing the saturation of magnetic silica, should take into account the fact that the silica matrix also adsorbs RNA and thereby affects the extraction yield of DNA. Stability of the lysates constitutes a supplementary advantage, as the extraction process can be delayed without loss of DNA and Boom lysis buffer blocks parasite development (e.g., stages and multiplication) immediately after sampling.

5. Conclusion

Nucleic acid extraction largely influences the quality and accuracy of the molecular diagnosis of parasitic diseases. Despite considerable progress regarding innocuity, convenience, and sample process automation, each user must test and consider the limits of each methodology. The advantage conferred by the NucliSENS easyMAG system relies on the high dissociation activity of lysis buffer, rendering PK digestion dispensable in most cases. However, preliminary mechanical disruption is necessary to yield sufficient levels of nucleic acids extracted from fungi and cysts. This system enables the quantitative extraction of DNA from paucicellular samples up to 105 cells, thereby allowing for a complete extraction process in less than 1 h.

Cite this article as: Jeddi F, Piarroux R & Mary C: Application of the NucliSENS easyMAG system for nucleic acid extraction: optimization of DNA extraction for molecular diagnosis of parasitic and fungal diseases. Parasite, 2013, 20, 52.

References

  • 1.Babaei Z, Oormazdi H, Rezaie S, Rezaeian M, Razmjou E. 2011. Giardia intestinalis: DNA extraction approaches to improve PCR results. Experimental Parasitology, 128, 159–162 [DOI] [PubMed] [Google Scholar]
  • 2.Baque RH, Gilliam AO, Robles LD, Jakubowski W, Slifko TR. 2011. A real-time RT-PCR method to detect viable Giardia lamblia cysts in environmental waters. Water Research, 45, 3175–3184 [DOI] [PubMed] [Google Scholar]
  • 3.Bernal-Martínez L, Gago S, Buitrago MJ, Gomez-Lopez A, Rodríguez-Tudela JL, Cuenca-Estrella M. 2011. Analysis of performance of a PCR-based assay to detect DNA of Aspergillus fumigatus in whole blood and serum: a comparative study with clinical samples. Journal of Clinical Microbiology, 49, 3596–3599 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Betson M, Halstead FD, Nejsum P, Imison E, Khamis IS, Sousa-Figueiredo JC, Rollinson D, Stothard JR. 2011. A molecular epidemiological investigation of Ascaris on Unguja, Zanzibar using isoenyzme analysis, DNA barcoding and microsatellite DNA profiling. Transactions of the Royal Society of Tropical Medicine and Hygiene, 105, 370–379 [DOI] [PubMed] [Google Scholar]
  • 5.Boom R, Sol CJ, Salimans MM, Jansen CL, Wertheim-van Dillen PM, van der Noordaa J. 1990. Rapid and simple method for purification of nucleic acids. Journal of Clinical Microbiology, 28, 495–503 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Bretagne S. 2011. Primary diagnostic approaches of invasive aspergillosis-molecular testing. Medical Mycology, 49, 48–53 [DOI] [PubMed] [Google Scholar]
  • 7.De Assis TS, Caligiorne RB, Romero GA, Rabello A. 2009. Detection of Leishmania kDNA in human serum samples for the diagnosis of visceral leishmaniasis. Transactions of the Royal Society of Tropical Medicine and Hygiene, 103, 1269–1272 [DOI] [PubMed] [Google Scholar]
  • 8.Higgins JA, Fayer R, Trout JM, Xiao L, Lal AA, Kerby S, Jenkins MC. 2001. Real-time PCR for the detection of Cryptosporidium parvum. Journal of Microbiological Methods, 47, 323–337 [DOI] [PubMed] [Google Scholar]
  • 9.Jaki BU, Franzblau SG, Cho SH, Pauli GF. 2006. Development of an extraction method for mycobacterial metabolome analysis. Journal of Pharmaceutical and Biomedical Analysis, 41, 196–200 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Ki J-S, Chang KB, Roh HJ, Lee BY, Yoon JY, Jang GY. 2007. Direct DNA isolation from solid biological sources without pretreatments with proteinase-K and/or homogenization through automated DNA extraction. Journal of Bioscience and Bioengineering, 103, 242–246 [DOI] [PubMed] [Google Scholar]
  • 11.Lau A, Halliday C, Chen SC, Playford EG, Stanley K, Sorrell TC. 2010. Comparison of whole blood, serum, and plasma for early detection of candidemia by multiplex-tandem PCR. Journal of Clinical Microbiology, 48, 811–816 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Laurendeau I, Bahuau M, Vodovar N, Larramendy C, Olivi M, Bieche I, Vidaud M, Vidaud D. 1999. TaqMan PCR-based gene dosage assay for predictive testing in individuals from a cancer family with INK4 locus haploinsufficiency. Clinical Chemistry, 45, 982–986 [PubMed] [Google Scholar]
  • 13.Liu AH, Guan GQ, Liu JL, Liu ZJ, Leblanc N, Li YQ, Gao JL, Ma ML, Niu QL, Ren QY, Bai Q, Yin H, Luo JX. 2011. Polymorphism analysis of Chinese Theileria sergenti using allele-specific polymerase chain reaction of the major piroplasm surface protein gene. Journal of Parasitology, 97, 116–121 [DOI] [PubMed] [Google Scholar]
  • 14.Mary C, Faraut F, Lascombe L, Dumon H. 2004. Quantification of Leishmania infantum DNA by a real-time PCR assay with high sensitivity. Journal of Clinical Microbiology, 42, 5249–5255 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Mary C, Faraut F, Deniau M, Dereure J, Aoun K, Ranque S, Piarroux R. 2010. Frequency of drug resistance gene amplification in clinical Leishmania strains. International Journal of Microbiology, 819060 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Mary C, Chapey E, Dutoit E, Guyot K, Hasseine L, Jeddi F, Menotti J, Paraud C, Pomares C, Rabodonirina M, Rieux A, Derouin F, ANOFEL Cryptosporidium National Network 2013. Multicentric evaluation of a new real-time PCR assay for quantification of Cryptosporidium spp. and identification of Cryptosporidium parvum and Cryptosporidium hominis. Journal of Clinical Microbiology, 51, 2556–2563 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Nasereddin A, Jaffe CL. 2010. Rapid diagnosis of Old World Leishmaniasis by high-resolution melting analysis of the 7SL RNA gene. Journal of Clinical Microbiology, 48, 2240–2242 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Nawrot U, Wlodarczyk K, Wrobel M, Wassik A. 2010. Comparison of the utility of five commercial kits for extraction of DNA from Aspergillus fumigatus spores. Acta Biochimica Polonica, 57, 567–571 [PubMed] [Google Scholar]
  • 19.Pontiroli A, Travis ER, Sweeney FP, Porter D, Gaze WH, Mason S, Hibberd V, Holden J, Courtenay O, Wellington EM. 2011. Pathogen quantitation in complex matrices: a multi-operator comparison of DNA extraction methods with a novel assessment of PCR inhibition. PLoS One, 6, 17916. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Schabereiter-Gurtner C, Selitsch B, Rotter ML, Hirschl AM, Willinger B. 2007. Development of novel real-time PCR assays for detection and differentiation of eleven medically important Aspergillus and Candida species in clinical specimens. Journal of Clinical Microbiology, 45, 906–914 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Schuurman T, van Breda A, de Boer R, Kooistra-Smid M, Beld M, Savelkoul P, Boom R. 2005. Reduced PCR sensitivity due to impaired DNA recovery with the MagNA Pure LC total nucleic acid isolation kit. Journal of Clinical Microbiology, 43, 4616–4622 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Van den Broeck F, Geldof S, Polman K, Volckaert FA, Huyse T. 2011. Optimal sample storage and extraction procotols for reliable multilocus genotyping of the human parasite Schistosoma mansoni. Infection Genetics and Evolution, 11, 1413–1418 [DOI] [PubMed] [Google Scholar]
  • 23.Van Lieshout EM, Van Doesburg W, Van der Meer R. 2004. Real-time PCR of host DNA in feces to study differential exfoliation of colonocytes between rats and humans. Scandinavian Journal of Gastroenterology, 39, 852–857 [DOI] [PubMed] [Google Scholar]
  • 24.White PL, Perry MD, Moody A, Follett SA, Morgan G, Barnes RA. 2011. Evaluation of analytical and preliminary clinical performance of Myconostica MycAssay Aspergillus when testing serum specimens for diagnosis of invasive Aspergillosis. Journal of Clinical Microbiology, 49, 2169–2174 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Parasite are provided here courtesy of EDP Sciences

RESOURCES